Daiwa Securities Group’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2K | Hold |
154
| – | – | ﹤0.01% | 1215 |
|
|
2025
Q1 | $2K | Hold |
154
| – | – | ﹤0.01% | 1184 |
|
|
2024
Q4 | $1K | Hold |
154
| – | – | ﹤0.01% | 1255 |
|
|
2024
Q3 | $2K | Hold |
154
| – | – | ﹤0.01% | 1220 |
|
|
2024
Q2 | $2K | Hold |
154
| – | – | ﹤0.01% | 1243 |
|
|
2024
Q1 | $2K | Buy |
+154
| New | +$2K | ﹤0.01% | 1263 |
|
|
2022
Q4 | – | Sell |
-46
| Closed | -$1K | – | 1333 |
|
|
2022
Q3 | $1K | Hold |
46
| – | – | ﹤0.01% | 1284 |
|
|
2022
Q2 | $0 | Hold |
46
| – | – | ﹤0.01% | 1377 |
|
|
2022
Q1 | $1K | Hold |
46
| – | – | ﹤0.01% | 1303 |
|
|
2021
Q4 | $1K | Hold |
46
| – | – | ﹤0.01% | 1332 |
|
|
2021
Q3 | $1K | Hold |
46
| – | – | ﹤0.01% | 1266 |
|
|
2021
Q2 | $1K | Hold |
46
| – | – | ﹤0.01% | 1192 |
|
|
2021
Q1 | $1K | Buy |
46
+12
| +35% | +$261 | ﹤0.01% | 1202 |
|
|
2020
Q4 | $1K | Buy |
+34
| New | +$1K | ﹤0.01% | 1181 |
|